Projects funded by the NCN
15-oxo-eicosatetraenoic acid (15-oxo-ETE) as a potential diagnostic biomarker of aspirin-exacerbated respiratory disease.
2021/41/B/NZ5/00305
Keywords:
aspirin-exacerbated respiratory disease 15-oxo-ETE in vitro diagnostic tests
Descriptors:
- NZ5_5: Diagnostics in human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 818 660 PLN
Project start date (Y-m-d): 2022-01-13
Project end date (Y-m-d): 2025-01-12
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.